Skip to content

Effect of Neuman System Model on hypertension control

The effect of Neuman Systems Model on hypertension control in hypertensive clients/patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180224038850N1
Enrollment
100
Registered
2018-03-18
Start date
2018-04-21
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension. Essential (primary) hypertension

Interventions

Intervention 1: Intervention group: Intervention include holding 2 individual session for complete the questionnaires and confirmation well-known risk factors by participants in experiment group, and

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Participants who diagnosed their hypertensions by physician and categoriesed their blood pressure in moderate to mild groups Having a systolic and diastolic blood pressure = 140/90 mmHg Participants were between 18 and 45 years ( because of limitation of comorbidity disease and effectiveness of change behavior in young adults) Participants were Zanjanian Not being in pregnancy and lactation period Participants were not with history of pectorice angina and type 2 diabetes and kidney disease Participant not being in any medicine groups Participants not participation synchronizely in another educational curriculum Having a primary hypertension

Exclusion criteria

Exclusion criteria: Participants who involved hypertension eventual problem such as CVA (cerebral vascular accident) that debar from participant in study Incidence problem that prevent participants from doing physical activity Participants request for excluding of study

Design outcomes

Primary

MeasureTime frame
The percent of people who have bood pressur = 140/90 mm Hg. Timepoint: This variable will be measurement once befor the intervention and again 2 month after the end of intervention also blood pressure in the middle part of intervention measurement again. Method of measurement: blood pressure will be measurement through valid pressure-gauge scale.;Blood lipids(cholesterol, TG). Timepoint: This variables will be measurement once befor the intervention and again 2 month after the end of intervention. Method of measurement: Blood lipids will be measurement in laboratory by Otoanalaysor system.;Body mass index. Timepoint: This variable will be measurement once befor the intervention and again 2 month after the end of intervention. Method of measurement: body mass index will be measurement through weight and height scale equipments.;Physical activity. Timepoint: This variable will be measurement once befor the intervention and again 2 month after the end of intervention. Method of measurement: Physical activity will be measurement through validity IPAQ questionnaire.;Nutrition. Timepoint: This variable will be measurement once befor the intervention and again 2 month after the end of intervention. Method of measurement: Nutrition will be measurement through valid DASH and FFQ questionnaires.;Stress management. Timepoint: This variable will be measurement once befor the intervention and again 2 month after the end of intervention. Method of measurement: stress will be measurement through valid perceived stress scale questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Hasani

Zanjan University of Medical Sciences

fatemehhasani2392@gmail.com+98 24 3352 0811

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026